Abstract:Background: Weight loss through lifestyle interventions, notably low-energy diets, offers glycemic benefits in populations with overweight-associated prediabetes. However, more than 50% of these individuals fail to achieve normoglycemia after weight loss. Circulating lipids hold potential for evaluating dietary impacts and predicting diabetes risk. Objective: This study sought to identify serum lipids that could serve as evaluative or predictive biomarkers for individual glycemic changes following diet-induced weight loss. Methods: We studied 104 participants with overweight-associated prediabetes, who lost ≥8% weight via a low-energy diet over eight weeks. High coverage lipidomics was conducted in serum samples before and after the dietary intervention. The lipidomic recalibration was assessed using Differential Lipid Abundance Comparisons and Partial Least Squares Discriminant Analyses. Associations between lipid changes and clinical characteristics were determined by Spearman's correlation and Bootstrap Forest of Ensemble Machine Learning model. Baseline lipids, predictive of glycemic parameters changes post-weight loss, were using Bootstrap Forest Analyses. Results: We quantified 439 serum lipid species and 9 related organic acids. Dietary intervention significantly reduced diacylglycerols, ceramides, lysophospholipids and ether-linked phosphatidylethanolamine. In contrast, acylcarnitines, short-chain fatty acids, organic acids, and ether-linked phosphatidylcholine were significantly increased. Changes in certain lipid species (e.g. saturated and monounsaturated fatty acid-containing glycerolipids, sphingadienine-based very long-chain sphingolipids and organic acids) were closely associated with clinical glycemic parameters. Six baseline bioactive sphingolipids primarily predicted changes in fasting plasma glucose. In addition, a number of baseline lipid species, mainly diacylglycerols and triglycerides, were predictive of clinical changes in hemoglobin A1c, insulin and HOMA-IR. Conclusions: Newly discovered serum lipidomic alterations and the associated changes in lipid-clinical variables suggest broad metabolic reprogramming related to diet-mediated glycemic control. Novel lipid predictors of glycemic outcomes could facilitate early stratification of individuals with prediabetes who are metabolically less responsive to weight loss, enabling more tailored intervention strategies beyond one-size-fits-all lifestyle modification advice. The PREVIEW lifestyle intervention study was registered at clinicaltrials.gov as NCT01777893 (https://clinicaltrials.gov/study/NCT01777893).

Gene expression profile of CD14+ blood monocytes following lifestyle-induced weight loss in individuals with metabolic syndrome

Network analyses reveal negative link between changes in adipose tissue GDF15 and BMI during dietary-induced weight loss

Weight Loss and Short-Chain Fatty Acids Reduce Systemic Inflammation in Monocytes and Adipose Tissue Macrophages from Obese Subjects

DNA methylation signature in blood mirrors successful weight-loss during lifestyle interventions: the CENTRAL trial

Central obesity is detrimental to anti-inflammatory, phenotype, and exhaustion markers in mononuclear cells - A cross-sectional study

Circulating MicroRNA Responses between ‘High’ and ‘Low’ Responders to a 16-Wk Diet and Exercise Weight Loss Intervention

Circulating MicroRNA-19 and Cardiovascular Risk Reduction in Response to Weight-loss Diets

Dietary Effects on Monocyte Phenotypes in Subjects With Hypertriglyceridemia and Metabolic Syndrome

Weight Changes Are Linked to Adipose Tissue Genes in Overweight Women with Polycystic Ovary Syndrome

The Impact of Weight Loss on Inflammation, Oxidative Stress, and Mitochondrial Function in Subjects with Obesity

Use of human PBMC to analyse the impact of obesity on lipid metabolism and metabolic status: a proof-of-concept pilot study

Subcutaneous adipose tissue gene expression and DNA methylation respond to both short- and long-term weight loss

Deep serum lipidomics identifies evaluative and predictive biomarkers for individualized glycemic responses following low-energy diet-induced weight loss: a PREVIEW sub-study

The Intestinal Microbiome Predicts Weight Loss on a Calorie-Restricted Diet and Is Associated With Improved Hepatic Steatosis

Exploratory analysis of the variable response to an intensive lifestyle change program for metabolic syndrome

Immunometabolic Signatures of Circulating Monocytes in Humans with Obesity and Insulin Resistance

Changes in leukocyte profile and C-reactive protein concentration in overweight and obese adolescents after reduction of body weight

[The influence of diet therapy and regular physical trainings on monocyte chemoattractant protein-1 (MCP-1) secretion by monocytes among obese patients with coronary heart disease]

Effects of Diet-Induced Weight Loss on Plasma Markers for Cholesterol Absorption and Synthesis: Secondary Analysis of a Randomized Trial in Abdominally Obese Men

Changes in circulating microRNAs-99/100 and reductions of visceral and ectopic fat depots in response to lifestyle interventions: the CENTRAL trial

Integrative metagenomic and lipidomic analyses reveal alterations in children with obesity and after lifestyle intervention